• 1
    Mac Glashan D. Jr (2003) Histamine: a mediator of inflammation. J Allergy Clin Immunol;112:S53S59.
  • 2
    Jarjour N., Calhoun W., Schwartz L., Busse W. (1991) Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis;144:8387.
  • 3
    Dunford P.J., O’Donnell N., Riley J.P., Williams K.N., Karlsson L., Thurmond R.L. (2006) The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4 T cells. J Immunol;176:70627070.
  • 4
    Liu C., Ma X.-J., Jiang X., Wilson S.J., Hofstra C.L., Blevitt J., Pyati J., Li X., Chai W., Carruthers N., Lovenberg T.W. (2000) Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol;59:420426.
  • 5
    Morse K.L., Behan J., Laz T.M., West R.E. Jr, Greenfeder S.A., Anthes J.C., Umland S. et al. (2001) Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther;296:10581066.
  • 6
    de Esch I.J., Thurmond R.L., Jongejan A., Leurs R. (2005) The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci;26:462469.
  • 7
    Fung-Leung W.-P., Thurmond R.L., Ling P., Karlsson L. (2004) Histamine H4 receptor antagonists: the new antihistamines? Curr Opin Investig Drugs;5:11741183.
  • 8
    Gutzmer R., Diestel C., Mommert S., Köther B., Stark H., Wittmann M., Werfel T. (2005) Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol;174:52245232.
  • 9
    Ling P., Ngo K., Nguyen S., Thurmond R.L., Edwards J.P., Karlsson L., Fung-Leung W.-P. (2004) Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol;142:161171.
  • 10
    Buckland K.F., Williams T.J., Conroy D.M. (2003) Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol;140:11171127.
  • 11
    Smits R.A., Leurs R., de Esch I.J. (2009) Major advances in the development of histamine H4 receptor ligands. Drug Discov Today;14:745753.
  • 12
    Klebe G. (2006) Foundation review: virtual ligand screening: strategies, perspectives and limitations. Drug Discov Today;11:580594.
  • 13
    Muegge I., Oloff S. (2006) Advances in virtual screening. Drug Discov Today;3:405411.
  • 14
    Thurmond R.L., Desai P.J., Dunford P.J., Fung-Leung W.-P., Hofstra C.L., Jiang W., Nguyen S., Riley J.P., Sun S., Williams K.N., Edwards J.P., Karlsson L. (2004) A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther;309:404413.
  • 15
    Coruzzi G., Adami M., Guaita E., de Esch I.J., Leurs R. (2007) Antinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ 7777120 and VUF 6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol;563:240244.
  • 16
    Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S.-I. (2000) Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem;275:3678136786.
  • 17
    Kiss R., Kiss B., Konczol A., Szalai F., Jelinek I., Laszlo V., Noszal B., Falus A., Keser G.M. (2008) Discovery of novel human histamine H4 receptor ligands by large- scale structure-based virtual screening. J Med Chem;51:31453153.
  • 18
    Hofman K., Stoffel W. (1993) TMBASE – a database of membrane spanning protein segments. J Biol Chem;374:166.
  • 19
    Sonhammer E.L.G., von Heijne G., Krogh A. (1998) A hidden Markov model for predicting transmembrane helices in protein sequences. In proceedings of the sixth international conference on systems for Molecular biology. ISBN:1-57735-053-7.
  • 20
    Tusnady G.E., Simon I. (2001) The HMMTOP transmembrane topology prediction server. Bioinformatics;17:849850.
  • 21
    Hirokawa T., Boon-Chieng S., Mitaku S. (1998) SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics;14:378379.
  • 22
    Zhang Y. (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics;9:40.
  • 23
    Zhang Y. (2008) Template-based modeling and free modeling by I-TASSER in CASP7. Proteins;8:108117.
  • 24
    Wu S., Skolnick J., Zhang Y. (2007) Ab initio modeling of small proteins by iterative TASSER simulations. BMC Biol;5:17.
  • 25
    Roy A., Kucukural A., Zhang Y. (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc;5:725738.
  • 26
    Laskowski R.A., Mac Arthur M.W., Moss D.S., Thornton J.M. (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr;26:283291.
  • 27
    Colovos C., Yeates T.O. (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci;2:15111519.
  • 28
    Kiss R., Noszal B., Racz A., Falus A., Eros D., Keseru G.M. (2008) Binding mode analysis and enrichment studies on homology models of the human histamine H4 receptor. Eur J Med Chem;43:10591070.
  • 29
    Xie X.-Q.S. (2010) Exploiting PubChem for virtual screening. Expert Opin Drug Discov;5:12051220.
  • 30
    Venkatachalam C.M., Jiang X., Oldfield T., Waldman M. (2003) LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graph Model;21:289307.
  • 31
    Thangapandian S., Krishnamoorthy N., John S., Sakkiah S., Lazar P., Lee Y., Lee K.W. (2010) Pharmacophore modeling, virtual screening and molecular docking studies for identification of new inverse agonists of human histamine H1 receptor. Bull Korean Chem Soc;31:5258.
  • 32
    Vollinga R.C., de Koning J.P., Jansen F.P., Leurs R., Menge W.M.P.B., Timmerman H. (1994) A new potent and selective histamine H3 receptor agonist, 4-(1H-imidazol-4-ylmethyl)piperidine. J Med Chem;37:332333.
  • 33
    Kitbunnadaj R., Zuiderveld O.P., Christophe B., Hulscher S., Menge W.M.P.B., Gelens E., Snip E., Bakker R.A., Celanire S., Gillard M., Talaga P., Timmerman H., Leurs R. (2004) Identification of 4-(1H-Imidazol-4(5)-ylmethyl)pyridine (Immethridine) as a novel, potent, and highly selective histamine H3 receptor agonist. J Med Chem;47:24142417.